Page last updated: 2024-11-12

ligstroside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ligstroside: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ligstroside : A secoiridoid glycoside that is the methyl ester of 3,4-dihydro-2H-pyran-5-carboxylic acid which is substituted at positions 2, 3, and 4 by hydroxy, ethylidene, and carboxymethyl groups, respectively and in which the anomeric hydroxy group at position 2 has been converted into its beta-D-glucoside and the carboxylic acid moiety of the carboxymethyl substituent has been converted to the corresponding 4-hydroxyphenethyl ester (the 2S,3E,4S stereoisomer). An important phenolic compound present in olive cultivars. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14136859
CHEMBL ID1086877
CHEBI ID149585
MeSH IDM0412850

Synonyms (21)

Synonym
ACON1_000577
MEGXP0_000487
NCGC00168945-01
BRD-K49137267-001-01-4
CHEMBL1086877
CHEBI:149585
35897-92-8
ligstroside
(-)-ligstroside
ligusroside
83s9sa69c5 ,
ligustroside
unii-83s9sa69c5
2h-pyran-4-acetic acid, 3-ethylidene-2-(.beta.-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-(4-hydroxyphenyl)ethyl ester, (2s,3e,4s)-
methyl (2s,3e,4s)-3-ethylidene-4-{2-[2-(4-hydroxyphenyl)ethoxy]-2-oxoethyl}-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-5-carboxylate
Q27269447
MS-29709
DTXSID701318124
CS-0024058
HY-N3383
AKOS040760521

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The aim of this work was to advance in the knowledge on the bioavailability of the secoiridoids present in a Fraxinus angustifolia Vahl seed/fruit extract using both targeted and untargeted metabolomic analyses."( Targeted and Untargeted Metabolomics to Explore the Bioavailability of the Secoiridoids from a Seed/Fruit Extract (Fraxinus angustifolia Vahl) in Human Healthy Volunteers: A Preliminary Study.
Fança-Berthon, P; García-Conesa, MT; García-Villalba, R; Issaly, N; Roller, M; Tomás-Barberán, FA; Zafrilla, P, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (6)

ClassDescription
secoiridoid glycosideA glycoside of any secoiridoid.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
diesterA diester is a compound containing two ester groups.
pyrans
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1498977Antiproliferative activity against human SKBR3 cells after 72 hrs by MTT reduction assay2017European journal of medicinal chemistry, Sep-08, Volume: 137New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivo.
AID466891Inhibition of GLUT42010Journal of natural products, Jan, Volume: 73, Issue:1
Iridoids from Fraxinus excelsior with adipocyte differentiation-inhibitory and PPARalpha activation activity.
AID466883Inhibition of adipocyte differentiation in mouse 3T3L1 cells assessed as inhibition of 2 deoxy-D[3H]glucose uptake at 0.01 mg/ml after 15 mins by scintillation counter relative to control2010Journal of natural products, Jan, Volume: 73, Issue:1
Iridoids from Fraxinus excelsior with adipocyte differentiation-inhibitory and PPARalpha activation activity.
AID466884Inhibition of adipocyte differentiation in mouse 3T3L1 cells assessed as inhibition of 2 deoxy-D[3H]glucose uptake at 0.1 mg/ml after 15 mins by scintillation counter relative to control2010Journal of natural products, Jan, Volume: 73, Issue:1
Iridoids from Fraxinus excelsior with adipocyte differentiation-inhibitory and PPARalpha activation activity.
AID466881Inhibition of adipocyte differentiation in mouse 3T3L1 cells assessed as inhibition of 2 deoxy-D[3H]glucose uptake at 0.5 mg/ml after 15 mins by scintillation counter relative to control2010Journal of natural products, Jan, Volume: 73, Issue:1
Iridoids from Fraxinus excelsior with adipocyte differentiation-inhibitory and PPARalpha activation activity.
AID625306Antioxidant activity assessed as superoxide radical scavenging activity after 20 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Secoiridoid glucosides and related compounds from Syringa reticulata and their antioxidant activities.
AID625307Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometric analysis2011Bioorganic & medicinal chemistry letters, Nov-01, Volume: 21, Issue:21
Secoiridoid glucosides and related compounds from Syringa reticulata and their antioxidant activities.
AID466879Inhibition of adipocyte differentiation in mouse 3T3L1 cells assessed as inhibition of 2 deoxy-D[3H]glucose uptake at 0.05 mg/ml after 15 mins by scintillation counter relative to control2010Journal of natural products, Jan, Volume: 73, Issue:1
Iridoids from Fraxinus excelsior with adipocyte differentiation-inhibitory and PPARalpha activation activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (24.14)29.6817
2010's15 (51.72)24.3611
2020's7 (24.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.78 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (96.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]